Second MedWatch Form Revision In Two Years Is Burdensome – AdvaMed
This article was originally published in The Gray Sheet
Executive Summary
FDA should grant a six-month grace period for firms to come into compliance with changes to the MedWatch adverse event reporting form, according to AdvaMed